Yonalink‘s collaboration with the AI4LUNGS consortium aims to create and validate AI tools and computational models to improve patient stratification and enhance lung health. By integrating their EHR-to-EDC streaming technology with AI-driven solutions, Yonalink and AI4LUNGS seek to revolutionize lung disease diagnosis, ultimately leading to better patient outcomes and more efficient healthcare delivery.
Yonalink is honored to have been selected to participate in the AI4LUNGS initiative that will lead to technology solutions that optimize diagnosis and treatment of respiratory diseases. Our unique approach to the management and streaming of patient data from the clinical partners, located in five countries, over the next three years, will ultimately provide the data engine needed to arrive at advanced solutions for personalized diagnosis and treatment planning which can improve patient outcomes and the overall standard of medical care by reducing the need for numerous examinations.
– said Iddo Peleg, CEO and co-founder of Yonalink.
Discover more here.